HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

In recent years, the pursuit of natural solutions to enhance metabolic health has gained prominence. Individuals are increasingly looking for ways to optimize their wellness without resorting to harsh ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it has earned a ...

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a ...

ARLINGTON, VIRGINIA / ACCESS Newswire / March 3, 2025 / Following the Food and Drug Administration's (FDA's) recent ...

Furthermore, GLP-1RAs produced through biological manufacturing techniques must abide by stringent regulatory standards, including the Good Manufacturing Practices, which are strictly enforced ...

Total revenue of $59.3 million for the fiscal year ended December 31, 2024Expect double digit growth for total revenue in 20252025 to demonstrate ...

A tool-based approach can significantly aid in the harmonization of regulatory requirements, mitigate inadvertent risks, and ...

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug ...

CDMOs and CROs share their most recent business highlights from the past twelve months on the oral solid dosage front.

Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today the appointment of Doug Hecker as Head of Technical Operations. With over 30 years of ...

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...